| scholarly article | Q13442814 |
| P2093 | author name string | Kenji Hamada | |
| Hisafumi Yamada-Okabe | |||
| Yoshinobu Kubota | |||
| Masashi Nakamura | |||
| Hiroji Uemura | |||
| Masahiro Yao | |||
| Hisashi Hasumi | |||
| Yasuhide Miyoshi | |||
| Yutaka Osada | |||
| Hitoshi Ishiguro | |||
| Shinpei Sugiura | |||
| Kiyoshi Fujinami | |||
| P2860 | cites work | Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke | Q44090679 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 911-916 | |
| P577 | publication date | 2005-07-01 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Neuroserpin (PI-12) is upregulated in high-grade prostate cancer and is associated with survival. | |
| P478 | volume | 115 |
| Q36539002 | Epigenetics and the plasticity of differentiation in normal and cancer stem cells |
| Q41483936 | Glaucoma is associated with plasmin proteolytic activation mediated through oxidative inactivation of neuroserpin. |
| Q46305320 | Mutation-, aging-, and gene dosage-dependent accumulation of neuroserpin (G392E) in endoplasmic reticula and lysosomes of neurons in transgenic mice |
| Q30847961 | Neonatal Hypoxia Ischaemia: Mechanisms, Models, and Therapeutic Challenges |
| Q46862408 | Pilot study of angiotensin II receptor blocker in advanced hormone-refractory prostate cancer |
| Q39548383 | Regulation of androgen receptor expression through angiotensin II type 1 receptor in prostate cancer cells |
| Q35160743 | Tissue plasminogen activator-independent roles of neuroserpin in the central nervous system |
Search more.